Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Related CVS
10 Notable Stocks Trading Ex-Dividend Thursday, October 20
Walgreens-Rite Aid Merger Is In Some Trouble Thanks To Kroger
DGI For The DIY: Q3 2016 Recap (Seeking Alpha)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Latest Ratings for CVS

Oct 2016UBSInitiates Coverage onBuy
Oct 2016BairdMaintainsOutperform
Oct 2016Bank of AmericaMaintainsBuy

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings


Related Articles (CVS)

View Comments and Join the Discussion!